Stock listing
NASDAQ:GELS Gelteq Limited Stock
Home listing (NASDAQ) of Gelteq Limited
Follow Gelteq Limited into a list and get an email when it puts out news.
Share price · NASDAQ:GELS
$0.461 USD -0.028 (-5.7%)
Close on Nov 4, 2026
- Day range
- $0.450 – $0.489 USDNov 4, 2026
- Volume
- 31,653 sharesNov 4, 2026
- Market cap
- $4.94M USDAt the close on Nov 4, 2026 · price × 10.71M shares outstanding
- 52-week range
- $0.387 – $2.010 USDLowest and highest trades, Nov 5, 2025 – Nov 4, 2026
- Traded on an average day
- $2.09M USDMedian day 39,450 shares · last 3 months, Aug 4, 2026 – Nov 4, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:GELS · Home | $0.461 USD | -0.028 (-5.7%) | 31,653 | $0.461 | $0.489 | $0.450 | $0.489 | Close on Nov 4, 2026 |
Daily closes
Last 3 months, Aug 4, 2026 – Nov 4, 2026 · NASDAQ:GELS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.461 | -0.028 | -5.7% | $0.461 | $0.489 | $0.450 | 31,653 | |
| $0.489 | -0.001 | -0.1% | $0.450 | $0.497 | $0.443 | 47,350 | |
| $0.490 | -0.001 | -0.1% | $0.469 | $0.490 | $0.462 | 9,126 | |
| $0.490 | -0.016 | -3.1% | $0.481 | $0.498 | $0.450 | 26,154 | |
| $0.506 | +0.025 | +5.1% | $0.500 | $0.530 | $0.480 | 77,067 | |
| $0.481 | +0.023 | +5.0% | $0.475 | $0.490 | $0.460 | 13,898 | |
| $0.458 | +0.011 | +2.5% | $0.444 | $0.471 | $0.430 | 28,037 | |
| $0.447 | +0.017 | +4.0% | $0.479 | $0.495 | $0.430 | 823,090 | |
| $0.430 | -0.005 | -1.1% | $0.436 | $0.446 | $0.430 | 12,693 | |
| $0.435 | -0.005 | -1.1% | $0.433 | $0.441 | $0.430 | 25,059 | |
| $0.440 | -0.008 | -1.8% | $0.452 | $0.456 | $0.440 | 10,261 | |
| $0.448 | +0.018 | +4.1% | $0.430 | $0.452 | $0.430 | 23,968 | |
| $0.430 | -0.016 | -3.5% | $0.452 | $0.465 | $0.430 | 190,527 | |
| $0.446 | +0.015 | +3.5% | $0.440 | $0.490 | $0.431 | 40,200 | |
| $0.431 | -0.019 | -4.2% | $0.446 | $0.450 | $0.430 | 18,700 | |
| $0.450 | -0.030 | -6.2% | $0.473 | $0.478 | $0.450 | 38,200 | |
| $0.480 | -0.010 | -2.0% | $0.490 | $0.528 | $0.480 | 62,900 | |
| $0.490 | -0.031 | -6.0% | $0.498 | $0.516 | $0.474 | 52,800 | |
| $0.521 | -0.028 | -5.1% | $0.559 | $0.559 | $0.521 | 52,400 | |
| $0.549 | -0.011 | -2.0% | $0.549 | $0.553 | $0.540 | 18,600 | |
| $0.560 | -0.020 | -3.4% | $0.571 | $0.580 | $0.550 | 89,300 | |
| $0.580 | +0.036 | +6.6% | $0.524 | $0.580 | $0.524 | 72,500 | |
| $0.544 | +0.023 | +4.4% | $0.538 | $0.571 | $0.520 | 37,300 | |
| $0.521 | -0.022 | -4.1% | $0.527 | $0.542 | $0.520 | 70,200 | |
| $0.543 | +0.013 | +2.5% | $0.532 | $0.554 | $0.500 | 200,300 | |
| $0.530 | -0.001 | -0.2% | $0.533 | $0.559 | $0.520 | 38,700 | |
| $0.531 | -0.016 | -2.9% | $0.540 | $0.546 | $0.522 | 55,600 | |
| $0.547 | +0.001 | +0.2% | $0.552 | $0.560 | $0.527 | 96,000 | |
| $0.546 | -0.004 | -0.7% | $0.546 | $0.547 | $0.525 | 79,300 | |
| $0.550 | -0.051 | -8.5% | $0.520 | $0.585 | $0.520 | 284,800 | |
| $0.601 | -0.009 | -1.5% | $0.542 | $0.637 | $0.526 | 524,200 | |
| $0.610 | +0.039 | +6.8% | $0.559 | $0.946 | $0.436 | 33,661,000 | |
| $0.571 | +0.009 | +1.6% | $0.558 | $0.601 | $0.558 | 31,600 | |
| $0.562 | -0.018 | -3.1% | $0.580 | $0.585 | $0.555 | 75,600 | |
| $0.580 | 0.000 | 0.0% | $0.609 | $0.609 | $0.566 | 63,300 | |
| $0.580 | -0.036 | -5.8% | $0.600 | $0.632 | $0.580 | 85,300 | |
| $0.616 | -0.064 | -9.4% | $0.668 | $0.668 | $0.580 | 97,000 | |
| $0.680 | -0.020 | -2.9% | $0.697 | $0.710 | $0.650 | 71,700 | |
| $0.700 | -0.087 | -11.1% | $0.780 | $0.780 | $0.700 | 92,300 | |
| $0.787 | -0.063 | -7.4% | $0.784 | $0.870 | $0.640 | 343,600 | |
| $0.850 | +0.174 | +25.7% | $0.660 | $0.850 | $0.636 | 700,200 | |
| $0.676 | -0.224 | -24.9% | $0.834 | $0.834 | $0.632 | 536,200 | |
| $0.900 | +0.007 | +0.8% | $0.805 | $0.900 | $0.771 | 1,462,800 | |
| $0.893 | +0.193 | +27.6% | $0.991 | $1.120 | $0.749 | 70,094,700 | |
| $0.700 | +0.168 | +31.6% | $0.569 | $0.826 | $0.532 | 71,637,600 | |
| $0.532 | -0.014 | -2.6% | $0.540 | $0.551 | $0.530 | 16,700 | |
| $0.546 | -0.010 | -1.8% | $0.549 | $0.549 | $0.542 | 4,300 | |
| $0.556 | -0.014 | -2.5% | $0.570 | $0.575 | $0.530 | 11,500 | |
| $0.570 | -0.010 | -1.7% | $0.565 | $0.580 | $0.551 | 16,600 | |
| $0.580 | +0.032 | +5.8% | $0.587 | $0.587 | $0.560 | 5,000 | |
| $0.548 | +0.016 | +3.0% | $0.526 | $0.589 | $0.526 | 37,100 | |
| $0.532 | -0.031 | -5.5% | $0.539 | $0.562 | $0.520 | 17,800 | |
| $0.563 | +0.005 | +0.9% | $0.589 | $0.589 | $0.537 | 21,000 | |
| $0.558 | +0.002 | +0.4% | $0.560 | $0.580 | $0.530 | 29,600 | |
| $0.556 | +0.024 | +4.5% | $0.530 | $0.590 | $0.530 | 11,200 | |
| $0.532 | -0.032 | -5.7% | $0.530 | $0.585 | $0.530 | 27,600 | |
| $0.564 | -0.016 | -2.8% | $0.602 | $0.617 | $0.560 | 35,000 | |
| $0.580 | -0.001 | -0.2% | $0.612 | $0.630 | $0.580 | 26,600 | |
| $0.581 | +0.010 | +1.8% | $0.591 | $0.612 | $0.570 | 11,100 | |
| $0.571 | +0.000 | +0.1% | $0.569 | $0.605 | $0.551 | 20,400 | |
| $0.571 | -0.014 | -2.4% | $0.576 | $0.601 | $0.570 | 12,976 | |
| $0.585 | +0.027 | +4.8% | $0.570 | $0.605 | $0.558 | 33,847 | |
| $0.558 | -0.016 | -2.8% | $0.583 | $0.583 | $0.546 | 11,400 | |
| $0.574 | +0.010 | +1.8% | $0.580 | $0.640 | $0.570 | 55,800 | |
| $0.564 | +0.030 | +5.6% | $0.540 | $0.585 | $0.540 | 53,800 | |
| $0.534 | -0.006 | -1.1% | $0.560 | $0.606 | $0.534 | 56,700 |
- Ticker
- NASDAQ:GELS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Jun 17, 2026
Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs
Latest deck · Dec 9, 2025
Investor Presentation (December 2025)
Investor deck · 21 slides
Latest news
Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs
Jun 17, 2026
Closed $1.14 (-7.3%) on Jun 17, 2026
Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications
Jun 12, 2026
Closed $0.99 (-35.3%) on Jun 12, 2026
Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion
Jun 4, 2026
Closed $0.514 (+5.8%) on Jun 4, 2026
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
May 20, 2026
Closed $0.455 (+16.7%) on May 20, 2026
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth
May 12, 2026
Closed $0.43 (-4.4%) on May 12, 2026
Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership
Feb 11, 2026
Closed $0.789 (-1.4%) on Feb 11, 2026
Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform
Jan 13, 2026
Closed $0.833 (+6.4%) on Jan 13, 2026
Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program
Dec 16, 2025
Closed $0.961 (+0.1%) on Dec 16, 2025
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China
Dec 9, 2025
Closed $1.12 (-0.9%) on Dec 9, 2025
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform
Dec 5, 2025
Closed $1.09 (-0.9%) on Dec 5, 2025
Decks
Investor Presentation (December 2025)
Investor deck · 21 slides · Dec 9, 2025
Gelteq Limited on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 31 in all · newest Jun 17, 2026 · oldest 2024
- Decks
- 1 deck · latest Dec 9, 2025
Where Gelteq Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:GELS · Home listing · This page | NASDAQ | United States | USD |
| BOATS:GELS | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Gelteq Limited.